What can we do to reduce the associated costs in induction of labour of intrauterine growth restriction foetuses at term? A cost-analysis study.

Jorge Duro-GómezMaría Fernanda Garrido-OyarzúnAna Belén Rodríguez-MarínAntonio Jesús de la Torre GonzálezJosé Eduardo Arjona-BerralCamil Castelo-Branco

Published in: Archives of gynecology and obstetrics (2017)

Misoprostol for induction of labour had lower related costs than dinoprostone or Cook® balloon, with similar obstetrical and perinatal outcomes.

Keyphrases

preterm infants
pregnant women
metabolic syndrome
gestational age
adipose tissue
skeletal muscle
insulin resistance